Brain

Weekly Recap: 10 Health Press Releases You Might Have Missed

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate…

1 year ago

Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

New clinical efficacy and safety data for arimoclomol as a possible treatment for Niemann-Pick disease type C, including from long-term…

1 year ago

IRLAB Participates in the Event Investing in Life Science: From Seed to Success

GOTHENBURG, SE / ACCESSWIRE / September 06, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 6, 2024 - IRLAB Therapeutics…

1 year ago

New England Biolabs® Announces 2024 Passion in Science Awards® Recipients

Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,…

1 year ago

Revitalist Lifestyle and Wellness Ltd. Partners with Wake Network to Launch Lion’s Brain Supplements for Enhanced Mental Clarity and Wellbeing

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),…

1 year ago

Real-Time Physiology in Cadavers: Is This an Oxymoron?

SANTA CLARA, Calif., Sept. 5, 2024 /PRNewswire/ -- Anatomage, Inc., today introduces upcoming upgrades to the Anatomage Table that simulate…

1 year ago

Lexaria Welcomes Industry Veteran as New CEO

Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC…

1 year ago

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference

MALVERN, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),…

1 year ago

Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14

Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated…

1 year ago